These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1454996)

  • 21. Effects of calcium channel blockers on experimental glomerular injury.
    Dworkin LD
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S21-7. PubMed ID: 16989074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glomerular cells and macrophages in the progression of experimental focal and segmental glomerulosclerosis.
    Matsumoto K; Atkins RC
    Am J Pathol; 1989 Apr; 134(4):933-45. PubMed ID: 2784942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rodent models of streptozotocin-induced diabetic nephropathy.
    Tesch GH; Allen TJ
    Nephrology (Carlton); 2007 Jun; 12(3):261-6. PubMed ID: 17498121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of impaired renal function in rats with streptozotocin-induced diabetes by transplantation of isolated pancreatic islets: failure in preventing the progress of glomerulosclerosis.
    Yamamoto T; Kawamura J; Yoshida O; Tobe T
    Nihon Geka Hokan; 1984 Nov; 53(6):721-35. PubMed ID: 6242013
    [No Abstract]   [Full Text] [Related]  

  • 25. Expression of beta1 integrins in glomerular tissue of Streptozotocin-induced diabetic rats.
    Regoli M; Bendayan M
    Biochem Cell Biol; 1999; 77(1):71-8. PubMed ID: 10426288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
    Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lovastatin ameliorates depressed intraglomerular proteolytic activities in experimental nephrotic syndrome.
    Teschner M; Paczek L; Schaefer L; Bahner U; Heidland A; Schaefer RM
    Res Exp Med (Berl); 1994; 194(6):349-56. PubMed ID: 7716342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study on renoprotective effect of Xuebijing and Rosiglitazone in rats with focal segmental glomerular fibrosis].
    Zhang BL; Li ZJ; Song LY; Zhang X; Wang WH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May; 20(5):299-300. PubMed ID: 18471366
    [No Abstract]   [Full Text] [Related]  

  • 29. Rapid induction of glomerular lipidosis in APA hamsters by streptozotocin.
    Han JS; Sugawara Y; Doi K
    Int J Exp Pathol; 1992 Feb; 73(1):75-84. PubMed ID: 1533531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal proteinases and kidney hypertrophy in experimental diabetes.
    Schaefer L; Schaefer RM; Ling H; Teschner M; Heidland A
    Diabetologia; 1994 Jun; 37(6):567-71. PubMed ID: 7926340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of glomerular and extracellular levels of glutathione peroxidase in patients and experimental rats with diabetic nephropathy.
    Chiu YW; Kuo MC; Kuo HT; Chang JM; Guh JY; Lai YH; Chen HC
    J Lab Clin Med; 2005 Apr; 145(4):181-6. PubMed ID: 15962836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Histopathological changes in the kidneys of the progeny of rats with aloxan diabetes].
    Nasledova ID; Sokoloverova IM; Obegova RF
    Probl Endokrinol (Mosk); 1979; 25(6):54-6. PubMed ID: 523442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased glomerular proteinase activity in the streptozotocin diabetic rat.
    Song RH; Singh AK; Leehey DJ
    Am J Nephrol; 1999; 19(3):441-6. PubMed ID: 10393385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?
    Remuzzi G; Bertani T
    Kidney Int; 1990 Sep; 38(3):384-94. PubMed ID: 2232481
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on the effect of protamine on the aminonucleoside nephropathy in rats--a trial to produce an experimental focal glomerular sclerosis (author's transl)].
    Saito T; Yamakage K; Kurosawa K; Kyogoku Y; Furuyama T; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1981 Oct; 23(10):1281-92. PubMed ID: 7334713
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical Management of Glomerular Diseases.
    Orr P; Shank BC; Hickson S; Cooke J
    Nurs Clin North Am; 2018 Dec; 53(4):551-567. PubMed ID: 30388981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal Trends in the Epidemiology of Biopsy-Proven Glomerular Diseases: An Alarming Increase in Diabetic Glomerulosclerosis.
    Hou J; Haas M
    Clin J Am Soc Nephrol; 2017 Apr; 12(4):556-558. PubMed ID: 28325867
    [No Abstract]   [Full Text] [Related]  

  • 38. Glomerular protocollagen lysyl-hydroxylase activity in streptozotocin diabetes.
    Khalifa A; Cohen MP
    Biochim Biophys Acta; 1975 Mar; 386(1):332-9. PubMed ID: 123780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation between urinary proteinases and proteinuria in rats with a glomerular disease.
    Davin JC; Davies M; Foidart JM; Foidart JB; Dechenne CA; Mahieu PR
    Adv Exp Med Biol; 1988; 240():267-73. PubMed ID: 3072845
    [No Abstract]   [Full Text] [Related]  

  • 40. A role for leptin in glomerulosclerosis?
    Ballermann BJ
    Kidney Int; 1999 Sep; 56(3):1154-5. PubMed ID: 10469386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.